Literature DB >> 18570397

Mechanistic studies of Cu(II) binding to amyloid-beta peptides and the fluorescence and redox behaviors of the resulting complexes.

Nakul C Maiti1, Dianlu Jiang, Andrew J Wain, Sveti Patel, Kim L Dinh, Feimeng Zhou.   

Abstract

Due in large part to the lack of crystal structures of the amyloid-beta (Abeta) peptide and its complexes with Cu(II), Fe(II), and Zn(II), characterization of the metal-Abeta complex has been difficult. In this work, we investigated the complexation of Cu(II) by Abeta through tandem use of fluorescence and electron paramagnetic resonance (EPR) spectroscopies. EPR experiments indicate that Cu(II) bound to Abeta can be reduced to Cu(I) using sodium borohydride and that both Abeta-Cu(II) and Abeta-Cu(I) are chemically stable. Upon reduction of Cu(II) to Cu(I), the Abeta fluorescence, commonly reported to be quenched upon Abeta-Cu(II) complex formation, can be regenerated. The absence of the characteristic tyrosinate peak in the absorption spectra of Abeta-Cu(II) complexes provides evidence that the sole tyrosine residue in Abeta is not one of the four equatorial ligands bound to Cu(II), but remains close to the metal center, and its fluorescence is sensitive to the copper oxidation state and perturbations in the coordination sphere. Further analysis of the quenching and Cu(II) binding behaviors at different Cu(II) concentrations and in the presence of the competing ligand glycine offers evidence supporting the operation of two binding regimes which demonstrate different levels of fluorescence recovery upon addition of the reducing agent. We provide results that suggest the fluorescence quenching is likely caused by charge transfer processes. Thus, by using tyrosine to probe the coordination site, fluorescence spectroscopy provides valuable mechanistic insights into the oxidation state of copper ions bound to Abeta, the binding heterogeneity, and the influence of solution conditions on complex formation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18570397     DOI: 10.1021/jp802038p

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  13 in total

1.  A kinetic model for beta-amyloid adsorption at the air/solution interface and its implication to the beta-amyloid aggregation process.

Authors:  Dianlu Jiang; Kim Lien Dinh; Travis C Ruthenburg; Yi Zhang; Lei Su; Donald P Land; Feimeng Zhou
Journal:  J Phys Chem B       Date:  2009-03-12       Impact factor: 2.991

2.  The elevated copper binding strength of amyloid-β aggregates allows the sequestration of copper from albumin: a pathway to accumulation of copper in senile plaques.

Authors:  Dianlu Jiang; Lin Zhang; Gian Paola G Grant; Christopher G Dudzik; Shu Chen; Sveti Patel; Yuanqiang Hao; Glenn L Millhauser; Feimeng Zhou
Journal:  Biochemistry       Date:  2013-01-11       Impact factor: 3.162

3.  Rapid assessment of human amylin aggregation and its inhibition by copper(II) ions by laser ablation electrospray ionization mass spectrometry with ion mobility separation.

Authors:  Hang Li; Emmeline Ha; Robert P Donaldson; Aleksandar M Jeremic; Akos Vertes
Journal:  Anal Chem       Date:  2015-10-06       Impact factor: 6.986

4.  Copper(II)-human amylin complex protects pancreatic cells from amylin toxicity.

Authors:  Elizabeth C Lee; Emmeline Ha; Sanghamitra Singh; Linda Legesse; Sana Ahmad; Elena Karnaukhova; Robert P Donaldson; Aleksandar M Jeremic
Journal:  Phys Chem Chem Phys       Date:  2013-08-14       Impact factor: 3.676

5.  Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-containing amyloid-beta complexes and aggregates.

Authors:  Dianlu Jiang; Xiangjun Li; Lin Liu; Gargey B Yagnik; Feimeng Zhou
Journal:  J Phys Chem B       Date:  2010-04-15       Impact factor: 2.991

6.  Copper chelating cyclic peptidomimetic inhibits Aβ fibrillogenesis.

Authors:  Sujan Kalita; Sourav Kalita; Altaf Hussain Kawa; Sukesh Shill; Anjali Gupta; Sachin Kumar; Bhubaneswar Mandal
Journal:  RSC Med Chem       Date:  2022-05-09

7.  Ternary complexes of iron, amyloid-beta, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer's disease.

Authors:  Dianlu Jiang; Xiangjun Li; Renee Williams; Sveti Patel; Lijie Men; Yinsheng Wang; Feimeng Zhou
Journal:  Biochemistry       Date:  2009-08-25       Impact factor: 3.162

8.  The amyloid-beta peptide of Alzheimer's disease binds Cu(I) in a linear bis-his coordination environment: insight into a possible neuroprotective mechanism for the amyloid-beta peptide.

Authors:  Jason Shearer; Veronika A Szalai
Journal:  J Am Chem Soc       Date:  2008-12-31       Impact factor: 15.419

9.  Conjugated Quantum Dots Inhibit the Amyloid β (1-42) Fibrillation Process.

Authors:  Garima Thakur; Miodrag Micic; Yuehai Yang; Wenzhi Li; Dania Movia; Silvia Giordani; Hongzhou Zhang; Roger M Leblanc
Journal:  Int J Alzheimers Dis       Date:  2011-03-02

10.  A central role for dityrosine crosslinking of Amyloid-β in Alzheimer's disease.

Authors:  Youssra K Al-Hilaly; Thomas L Williams; Maris Stewart-Parker; Lenzie Ford; Eldhose Skaria; Michael Cole; William Grant Bucher; Kyle L Morris; Alaa Abdul Sada; Julian R Thorpe; Louise C Serpell
Journal:  Acta Neuropathol Commun       Date:  2013-12-18       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.